By Peter Laird, MD
NxStage announced the seven year anniversary of its first patients to go home on the NxStage System One, the only FDA approved home dialysis system in America. These patients came from the original studies on the NxStage System One and they have simply continued without going back to the usual in-center care:
Everette had been undergoing in-center dialysis treatments when he learned about daily home hemodialysis with NxStage. "For the past seven years, the NxStage System One has given me the freedom to live my life closer to the way I want to live it and allowed me to dedicate more time to my hobbies and business dreams," he said. "Thanks in part to NxStage and dialyzing more frequently, I feel more healthy and active. I've come off several blood pressure medications and play basketball twice a week while spearheading my online clothing store."
"This is a tremendous milestone not only for these patients, but also for all of our patients, prescribing nephrologists, partners and employees," stated Jeffrey H. Burbank, founder and CEO of NxStage Medical, Inc. "We are extremely gratified to see these patients thriving and are excited to expand access to the life changing benefits possible with more frequent home hemodialysis using the System One to a growing number of patients worldwide."
Congratulations to NxStage with not only their success in the clinical arena of home dialysis, but also in the fact that they are the first financial sustainable home dialysis corporation which is opening up the doors to further improvements and competition among other dialysis providers. I am personally thankful for this extraordinary little machine that has given me the freedom and the oppportunity to obtain daily dialysis, the only proven dialysis strategy that improves the burden of disease for dialysis patients as shown in the recent FHN.
Comments